Singh S, Dash AK. Chapter 3 - Physical properties, their determination, and importance in pharmaceutics. In: Dash AK, Singh S, editors. Pharmaceutics: basic principles and application to pharmacy practice. 2nd ed. Academic; 2024. pp. 67–113.

Deb PK, Al-Attraqchi O, Jaber AY, Amarji B, Tekade RK. In: Tekade RK, editor. Chapter 2 - Physicochemical aspects to be considered in pharmaceutical product development. Dosage Form Design Considerations: Academic; 2018. pp. 57–83.

Google Scholar 

Aulton ME, Taylor KMG. Aulton’s pharmaceutics: the design and manufacture of medicines. Amsterdam: Elsevier; 2021.

Google Scholar 

Davis AM, Leeson PD. Physicochemical properties. In: Ward SE, Davis A, editors. The handbook of medicinal chemistry: principles and practice. Cambridge, United Kingdom: The Royal Society of Chemistry; 2023.

Google Scholar 

Kumar P, Pradeep P, Indermun S, Govender M, Choonara YE, Pillay V. Physicochemical basic principles for solid dosage forms. In: Pathak Y, dos Araújo M, Zea L, editors. Handbook of space pharmaceuticals. Cham: Springer International Publishing; 2018. pp. 1–19.

Google Scholar 

Lohani S, Cooper H, Jin X, Nissley BP, Manser K, Rakes LH, et al. Physicochemical properties, form, and formulation selection strategy for a biopharmaceutical classification system class II preclinical drug candidate. J Pharm Sci. 2014;103(10):3007–21.

Article  CAS  PubMed  Google Scholar 

Losada-Barreiro S, Celik S, Sezgin-Bayindir Z, Bravo-Fernández S, Bravo-Díaz C. Carrier systems for advanced drug delivery: improving drug solubility/bioavailability and administration routes. Pharmaceutics. 2024;16(7):852.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rocha B, de Morais LA, Viana MC, Carneiro G. Promising strategies for improving oral bioavailability of poor water-soluble drugs. Expert Opin Drug Discov. 2023;18(6):615–27.

Article  PubMed  Google Scholar 

Kumari L, Choudhari Y, Patel P, Gupta GD, Singh D, Rosenholm JM, et al. Advancement in solubilization approaches: a step towards bioavailability enhancement of poorly soluble drugs. Life (Basel). 2023;13(5):1099.

CAS  PubMed  Google Scholar 

Serajuddin ATM. Salt formation to improve drug solubility. Adv Drug Deliv Rev. 2007;59(7):603–16.

Article  CAS  PubMed  Google Scholar 

Elder DP, Holm R, Diego HL. Use of pharmaceutical salts and cocrystals to address the issue of poor solubility. Int J Pharm. 2013;453(1):88–100.

Article  CAS  PubMed  Google Scholar 

Bharate SS. Carboxylic acid counterions in FDA-approved pharmaceutical salts. Pharm Res. 2021;38(8):1307–26.

Article  CAS  PubMed  Google Scholar 

Dhaval M, Dudhat K, Gadoya A, shah S, Pethani T, Jambukiya N, Patel A, Kalsariya C, Ansari J, Borkhataria C. Pharmaceutical salts: comprehensive insights from fundamental chemistry to FDA approvals (2019–2023). AAPS PharmSciTech. 2025;26(1):36.

Article  PubMed  Google Scholar 

Yan H, Zhong X, Liu Y. Improving the solubility, stability, and bioavailability of albendazole through synthetic salts. Molecules. 2024;29(15):3571.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kapourani A, Pantazos I, Skoutida S, Assimopoulou AN, Barmpalexis P. Harnessing dicarboxylate-based salts for enhancing the performance of amorphous solid dispersions: the case of olanzapine. Eur J Pharm Biopharm. 2025;214:114782.

Article  CAS  PubMed  Google Scholar 

Hu X, Xiao Y, Qi L, Bai Y, Sun Y, Ye Y, et al. Enhancing the dissolution and bacteriostatic activity of Trimethoprim through salt formation. CrystEngComm. 2023;25(23):3445–59.

Article  CAS  Google Scholar 

Zhang Y, Li Y, Zhang Y, Liu L, Zou D, Sun W, et al. Improved solubility and hygroscopicity of Enoxacin by pharmaceutical salts formation with hydroxybenzonic acids via charge assisted hydrogen bond. J Mol Struct. 2023;1273:134272.

Article  CAS  Google Scholar 

Li J, Song S, Huang W, Fan H, Zhou Z. Novel drug-drug salts of Enoxacin with enhanced antibacterial activity: insights from solubility and lipid-water partition coefficient. J Mol Liq. 2023;385:122443.

Article  CAS  Google Scholar 

Nadagouda MN, Vijayasarathy P, Sin A, Nam H, Khan S, Parambath JBM, et al. Antimicrobial activity of quaternary ammonium salts: structure-activity relationship. Med Chem Res. 2022;31(10):1663–78.

Article  CAS  Google Scholar 

Alfei S. Shifting from ammonium to phosphonium salts: a promising strategy to develop next-generation weapons against biofilms. Pharmaceutics. 2024;16(1):80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hossain Mithu MS, Economidou S, Trivedi V, Bhatt S, Douroumis D. Advanced methodologies for pharmaceutical salt synthesis. Cryst Growth Des. 2021;21(2):1358–74.

Article  CAS  Google Scholar 

Abrantes CG, Duarte D, Reis CP. An overview of pharmaceutical excipients: safe or not safe? J Pharm Sci. 2016;105(7):2019–26.

Article  CAS  PubMed  Google Scholar 

Mugglestone CJ, Mariz S, Lane ME. The development and registration of topical pharmaceuticals. Int J Pharm. 2012;435(1):22–6.

Article  CAS  PubMed  Google Scholar 

David SE, Timmins P, Conway BR. Impact of the counterion on the solubility and physicochemical properties of salts of carboxylic acid drugs. Drug Dev Ind Pharm. 2012;38(1):93–103.

Article  CAS  PubMed  Google Scholar 

Elder DP, Delaney E, Teasdale A, Eyley S, Reif VD, Jacq K, et al. The utility of sulfonate salts in drug development. J Pharm Sci. 2010;99(7):2948–61.

Article  CAS  PubMed  Google Scholar 

Gupta D, Bhatia D, Dave V, Sutariya V, Varghese Gupta S. Salts of therapeutic agents: chemical, physicochemical, and biological considerations. Molecules. 2018. https://doi.org/10.3390/molecules23071719.

Article  PubMed  PubMed Central  Google Scholar 

Bharate SS. Modulation of biopharmaceutical properties of drugs using sulfonate counterions: a critical analysis of FDA-approved pharmaceutical salts. J Drug Deliv Sci Technol. 2021;66:102913.

Article  CAS  Google Scholar 

Fulmali A, Bharate SS. Phosphate moiety in FDA-approved pharmaceutical salts and prodrugs. Drug Dev Res. 2022;83(5):1059–74.

Article  CAS  PubMed  Google Scholar 

Hua X-N, Pan X, Zhu Y, Cai Z, Song Q, Li Y, et al. Novel pharmaceutical salts of cephalexin with organic counterions: structural analysis and properties. RSC Adv. 2022;12(54):34843–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hibbard T, Nyambura B, Scholes P, Totolici M, Shankland K, Al-Obaidi H. Preparation and physiochemical analysis of novel ciprofloxacin / dicarboxylic acid salts. J Pharm Sci. 2023;112(1):195–203.

Article  CAS  PubMed  Google Scholar 

Paluch KJ, McCabe T, Müller-Bunz H, Corrigan OI, Healy AM, Tajber L. Formation and physicochemical properties of crystalline and amorphous salts with different stoichiometries formed between ciprofloxacin and succinic acid. Mol Pharm. 2013;10(10):3640–54.

Article  CAS  PubMed  Google Scholar 

Inactive Ingredient Search for Approved Drug Products [Internet]. 2025 [cited 1 January 2025]. Available from: https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm

Liao Z, Yeoh Y-K, Parumasivam T, Koh WY, Alrosan M, Alu’datt MH, et al. Medium-chain dicarboxylic acids: chemistry, pharmacological properties, and applications in modern pharmaceutical and cosmetics industries. RSC Adv. 2024;14(24):17008–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fiume MM, eldreth H, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, et al. Final report of the cosmetic ingredient review expert panel on the safety assessment of dicarboxylic acids, salts, and esters. Int J Toxicol. 2012;31(4suppl):S5-76.

Article  Google Scholar 

Hussen NHA, Qadir SH, Rahman HS, Hamalaw YY, Kareem PSS, Hamza BA. Long-term toxicity of fluoroquinolones: a comprehensive review. Drug Chem Toxicol. 2024;47(5):795–806.

Article  CAS  PubMed